Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Paychex Hits 52-Week High, Expanding Customer Base Holds Key

Published 11/30/2017, 09:44 PM
Updated 07/09/2023, 06:31 AM

Shares of Paychex, Inc. (NASDAQ:PAYX) touched a 52-week high of $67.88, eventually closing at $67.31 on Nov 30, 2017. The stock has gained 10.6% year to date, substantially outperforming the 6.1% rally of the industry it belongs to.

The outperformance can be accredited to the company’s expanding customer base and its solid domain expertise in human capital management solutions for payroll, HR, retirement, and insurance services.

Paychex’s sustained focus on investing in product development and enhancing sales force capabilities is helping it to add customers, thereby supporting revenue growth. Notably, revenues witnessed 5-year (2012-2017) CAGR of 7.2%. Higher revenues are likely to expand margins and increase profitability in the long run.

Investors seems to be impressed with Paychex’s latest acquisition of HR Outsourcing Holdings, Inc. (HROI), which has provided it an opportunity to grab market share in the fast growing professional employer organization (PEO) industry. In our opinion, the acquisition is a strategic fit for Paychex as more and more companies are willing to use PEO services rather than creating their in-house HR management departments.

The company’s initiatives to boost revenue growth through acquisitions are encouraging. Since its inception, the company has completed 14 acquisitions. These buyouts have helped Paychex to expand its services as well as global reach, thereby boosting its revenues.
Additionally, the industry in which Paychex operates has huge growth potential. The company mainly focuses on small- and mid-sized businesses looking for HR solutions. Paychex has nearly 605,000 payroll clients but the market is still highly untapped. Per the company, there are about 12 million businesses in the United States under its total addressable market, half of which are still untapped.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Nonetheless, the company has been witnessing lower client retention in the last few quarters, which remains a concern for the near term. Also, current political uncertainty may adversely impact outsourcing decision making in the mid-market, thereby affecting Paychex’s overall growth prospect.

Zacks Rank & Stocks to Consider

Paychex currently carries a Zacks Rank #3 (Hold).

Intel Corporation (NASDAQ:INTC) , IPG Photonics Corporation (NASDAQ:IPGP) and NVIDIA Corporation (NASDAQ:NVDA) are three better-ranked stocks in the broader technology sector. All of them sport a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term earnings growth for Intel, IPG Photonics and NVIDIA is currently projected to be 8.4%, 19.67% and 11.2% respectively.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



IPG Photonics Corporation (IPGP): Free Stock Analysis Report

Intel Corporation (INTC): Free Stock Analysis Report

NVIDIA Corporation (NVDA): Free Stock Analysis Report

Paychex, Inc. (PAYX): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.